Income Statement American Oncology Network, Inc.

Stocks

AONC

US0287191029

Healthcare Facilities & Services

Market Closed - OTC Markets 09:31:54 2026-05-27 EDT			5-day change	1st Jan Change
10.00 ^USD	-16.67%		-9.09%	-16.67%

06-11	American Oncology Network Appoints Ella Friedman as President, Network Operations	CI
06-10	American Oncology Network and Colla Health Partner to Expand Whole-Person Cancer Care and Behavioral Health Support In Community Oncology	CI

d710757f0ffa5af.7hm9gePchBUNvYdL4u9IfWhVlJg2oZtG_LA6SpelRjQ.tkCP5LOZySU-9OokpZx_EAIg3vBX5e8vhepZJ9_IMGaGctjEl6zKT2r5tw

Published financial data: AMERICAN ONCOLOGY NETWORK, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)
Revenues	715M	938M	1.14B	1.27B	1.74B
Other Revenues, Total	3.22M	5.5M	11.74M	13.47M	15.51M
Total Revenues	718M	944M	1.15B	1.28B	1.76B
Cost of Goods Sold, Total	659M	866M	1.05B	1.19B	1.64B
Gross Profit	59.26M	77.96M	98.1M	90.31M	120M
Selling General & Admin Expenses, Total	44.03M	77.05M	92.53M	103M	137M
Other Operating Expenses, Total	44.03M	77.05M	92.53M	103M	137M
Operating Income	15.23M	911K	5.57M	-13.12M	-16.09M
Interest Expense, Total	-1.12M	-1.42M	-3.42M	-6.42M	-7.06M
Interest And Investment Income	32K	127K	151K	1.33M	3.2M
Net Interest Expenses	-1.08M	-1.29M	-3.27M	-5.09M	-3.86M
Income (Loss) On Equity Invest.	-	-	-	-259K	153K
Other Non Operating Income (Expenses)	180K	736K	289K	-8.26M	-3.84M
EBT, Excl. Unusual Items	14.33M	355K	2.59M	-26.73M	-23.64M
Merger & Related Restructuring Charges	-	-	-	-31.24M	-1.34M
Other Unusual Items	6.84M	-	-	22.28M	514K
EBT, Incl. Unusual Items	21.17M	355K	2.59M	-35.69M	-24.46M
Income Tax Expense	-783K	460K	-	384K	2.5M
Earnings From Continuing Operations	21.95M	-105K	2.59M	-36.07M	-26.96M
Net Income to Company	21.95M	-105K	2.59M	-36.07M	-26.96M
Minority Interest	-	-	-	30.53M	22.98M
Net Income - (IS)	21.95M	-105K	2.59M	-5.54M	-3.97M
Preferred Dividend and Other Adjustments	2.52M	-	80K	3.58M	5.55M
Net Income to Common Incl Extra Items	19.43M	-105K	2.51M	-9.12M	-9.52M
Net Income to Common Excl. Extra Items	19.43M	-105K	2.51M	-9.12M	-9.52M
Per Share Items
Net EPS - Basic	-	-	-	-1.36	-0.69
Basic EPS - Continuing Operations	-	-	-	-1.36	-0.69
Basic Weighted Average Shares Outstanding	-	-	-	6.69M	13.72M
Net EPS - Diluted	-	-	-	-1.36	-0.89
Diluted EPS - Continuing Operations	-	-	-	-1.36	-0.89
Diluted Weighted Average Shares Outstanding	-	-	-	6.69M	37.5M
Normalized Basic EPS	-	-	-	2.07	0.6
Normalized Diluted EPS	-	-	-	2.07	0.22
Payout Ratio	-	-	-	-171.06	-
Supplemental Items
EBITDA	18.89M	6.99M	12.28M	-4.67M	-5.58M
EBITA	15.23M	911K	5.57M	-13.12M	-16.09M
EBIT	15.23M	911K	5.57M	-13.12M	-16.09M
EBITDAR	30.19M	23.19M	27.49M	8.83M	9.47M
Total Revenues (As Reported)	725M	944M	1.15B	1.28B	1.76B
Effective Tax Rate - (Ratio)	-3.7	129.58	-	-1.08	-10.21
Current Domestic Taxes	275K	-326K	-	-	-236K
Total Current Taxes	275K	-326K	-	-	-236K
Deferred Domestic Taxes	-1.06M	786K	-	384K	2.73M
Total Deferred Taxes	-1.06M	786K	-	384K	2.73M
Normalized Net Income	8.95M	222K	1.62M	13.82M	8.21M
Interest on Long-Term Debt	1.12M	1.42M	3.48M	6.55M	7.38M
Supplemental Operating Expense Items
General and Administrative Expenses	44.03M	77.05M	89.89M	101M	134M
Net Rental Expense, Total	11.3M	16.2M	15.2M	13.5M	15.04M
Imputed Operating Lease Interest Expense	-	3.67M	4.32M	5.3M	5.99M
Imputed Operating Lease Depreciation	-	12.53M	10.88M	8.2M	9.05M
Stock-Based Comp., COGS (Total)	-	-	-	4.8M	-
Stock-Based Comp., Other (Total)	20K	20K	-	77K	17.68M
Total Stock-Based Compensation	20K	20K	-	4.88M	17.68M

Fiscal Period: December	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)
Assets
Cash And Equivalents	42.84M	27.35M	26.93M	28.54M	62.85M
Short Term Investments	-	-	9.85M	35.39M	9.79M
Total Cash And Short Term Investments	42.84M	27.35M	36.78M	63.93M	72.64M
Accounts Receivable, Total	80.42M	111M	136M	129M	129M
Other Receivables	15.72M	25.08M	28.2M	34.27M	58.2M
Notes Receivable	1.78M	1.81M	1.8M	1.6M	2.2M
Total Receivables	97.92M	138M	166M	165M	190M
Inventory	22.06M	34.53M	36.48M	44.57M	60.71M
Prepaid Expenses	1.39M	3.28M	2.67M	4.28M	8.49M
Restricted Cash	-	5M	-	-	-
Total Current Assets	164M	208M	242M	278M	331M
Gross Property Plant And Equipment	33.47M	43.28M	93.05M	108M	128M
Accumulated Depreciation	-4.81M	-10.63M	-17.35M	-24.64M	-29.79M
Net Property Plant And Equipment	28.66M	32.65M	75.7M	83.79M	98.53M
Goodwill	-	-	-	-	10.9M
Other Intangibles, Total	475K	1.11M	1.23M	1.23M	2.48M
Loans Receivable Long-Term	4.61M	3.15M	2.08M	1.15M	1.36M
Deferred Tax Assets Long-Term	786K	-	-	2.89M	-
Other Long-Term Assets, Total	2.09M	3.11M	5.2M	7.59M	25.58M
Total Assets	201M	248M	326M	374M	470M
Liabilities
Accounts Payable, Total	70.34M	92.91M	106M	128M	171M
Accrued Expenses, Total	7.31M	14.01M	9.92M	17.47M	20.96M
Short-term Borrowings	10M	-	-	-	-
Current Portion of Long-Term Debt	10.8M	-	-	-	3.74M
Current Portion of Leases	-	-	9.6M	7.88M	8.48M
Current Income Taxes Payable	-	-	-	971K	734K
Unearned Revenue Current, Total	17.19M	3.74M	-	-	-
Other Current Liabilities	6.83M	8.68M	14.92M	15.08M	12.19M
Total Current Liabilities	122M	119M	141M	169M	217M
Long-Term Debt	15.7M	63.69M	80.3M	80.64M	87.12M
Long-Term Leases	-	-	38.84M	44.35M	51.4M
Other Non Current Liabilities	3.03M	5.72M	4.13M	9.7M	6.96M
Total Liabilities	141M	189M	264M	304M	362M
Preferred Stock Convertible	-	-	-	64.99M	64.99M
Total Preferred Equity	-	-	-	64.99M	64.99M
Common Stock, Total	36.28M	36.3M	36.3M	4K	4K
Additional Paid In Capital	-	-	-	-	56.29M
Retained Earnings	23.34M	23.24M	25.83M	-162M	-102M
Treasury Stock	-	-	-	-	-368K
Comprehensive Income and Other	-	-	-117K	81K	28K
Total Common Equity	59.63M	59.54M	62.02M	-162M	-46.22M
Minority Interest	-	-	-	167M	89.24M
Total Equity	59.63M	59.54M	62.02M	70.71M	108M
Total Liabilities And Equity	201M	248M	326M	374M	470M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	-	-	-	10.61M	32.09M
ECS Total Common Shares Outstanding	-	-	-	9.52M	30.19M
Book Value / Share	-	-	-	-16.99	-1.53
Tangible Book Value	59.15M	58.43M	60.79M	-163M	-59.59M
Tangible Book Value Per Share	-	-	-	-17.12	-1.97
Total Debt	36.5M	63.69M	129M	133M	151M
Net Debt	-6.34M	36.34M	91.97M	68.94M	78.1M
Debt Equivalent Oper. Leases	90.4M	130M	122M	108M	120M
Minority Interest, Total (Incl. Fin. Div)	-	-	-	167M	89.24M
Account Code - Inventory Valuation	-	5	5	5	5
Inventories - Finished Goods, Total	22.06M	34.53M	36.48M	44.57M	60.71M
Machinery, Total	10.2M	13.94M	16.86M	21.62M	17.49M
Full Time Employees	-	-	1.52K	1.52K	1.91K

Fiscal Period: December	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)
Net Income	21.95M	-105K	2.59M	-5.54M	-3.97M
Depreciation & Amortization - CF	3.66M	6.08M	17.08M	16.74M	19.37M
Depreciation & Amortization, Total	3.66M	6.08M	17.08M	16.74M	19.37M
Amortization of Deferred Charges, Total - (CF)	19K	363K	627K	787K	609K
(Gain) Loss From Sale Of Asset	-	-79K	-121K	-289K	4.5M
(Income) Loss On Equity Investments - (CF)	-	-	-	259K	-153K
Stock-Based Compensation (CF)	20K	20K	-	4.87M	14.42M
Other Operating Activities, Total	-527K	2.16M	-	-47.02M	-19.35M
Change In Accounts Receivable	-35.48M	-30.8M	-24.87M	6.95M	-771K
Change In Inventories	-6.27M	-10.26M	-1.95M	-8.09M	-13.67M
Change In Accounts Payable	34M	21.68M	14.08M	20.07M	39.49M
Change in Other Net Operating Assets	19.88M	-15.39M	-14.22M	-6.85M	-45.42M
Cash from Operations	37.24M	-26.34M	-6.78M	-18.12M	-4.94M
Capital Expenditure	-12.22M	-8.32M	-7.19M	-12.28M	-20.95M
Sale of Property, Plant, and Equipment	-	683K	2.08M	704K	218K
Cash Acquisitions	-933K	-3.22M	-5K	-	-6.71M
Investment in Marketable and Equity Securities, Total	-	-	-9.97M	-25.08M	26.1M
Other Investing Activities, Total	-1.52M	160K	1.09M	1.12M	-1.06M
Cash from Investing	-14.67M	-10.69M	-13.99M	-35.53M	-2.41M
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	12.52M	65M	16.25M	-	-
Total Debt Issued	12.52M	65M	16.25M	-	-
Short Term Debt Repaid, Total	-12.06M	-10M	-	-	-
Long-Term Debt Repaid, Total	-12.52M	-27.3M	-426K	-593K	-4.71M
Total Debt Repaid	-24.58M	-37.3M	-426K	-593K	-4.71M
Issuance of Common Stock	28.5M	-	-	-	50M
Repurchase of Common Stock	-	-	-	-89K	-3.63M
Issuance of Preferred Stock	-	-	-	65M	-
Preferred Dividends Paid	-	-	-	-9.48M	-
Common & Preferred Stock Dividends Paid	-	-	-	-9.48M	-
Other Financing Activities, Total	-177K	-1.15M	-477K	431K	-
Cash from Financing	16.26M	26.54M	15.35M	55.26M	41.66M
Net Change in Cash	38.83M	-10.49M	-5.43M	1.61M	34.31M
Supplemental Items
Cash Interest Paid	1.1M	1.38M	2.18M	5.85M	5.74M
Cash Income Tax Paid (Refund)	335K	-	-	-	-
Levered Free Cash Flow	-	-44.06M	-467K	19.11M	740K
Unlevered Free Cash Flow	-	-43.53M	1.04M	22.33M	4.54M
Change In Net Working Capital	-	41.88M	12.33M	-21.2M	1.5M
Net Debt Issued / Repaid	-12.06M	27.7M	15.82M	-593K	-4.71M

Fiscal Period: December	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)
Profitability
Return on Assets	-	0.25	1.21	-2.34	-2.38
Return on Total Capital	-	0.52	2.22	-4.16	-4.35
Return On Equity %	-	-0.18	4.26	-54.35	-30.17
Return on Common Equity	-	-0.18	4.13	18.3	9.16
Margin Analysis
Gross Profit Margin %	8.26	8.26	8.53	7.06	6.85
SG&A Margin	6.13	8.16	8.05	8.09	7.76
EBITDA Margin %	2.63	0.74	1.07	-0.36	-0.32
EBITA Margin %	2.12	0.1	0.48	-1.03	-0.91
EBIT Margin %	2.12	0.1	0.48	-1.03	-0.91
Income From Continuing Operations Margin %	3.06	-0.01	0.23	-2.82	-1.53
Net Income Margin %	3.06	-0.01	0.23	-0.43	-0.23
Net Avail. For Common Margin %	2.71	-0.01	0.22	-0.71	-0.54
Normalized Net Income Margin	1.25	0.02	0.14	1.08	0.47
Levered Free Cash Flow Margin	-	-4.67	-0.04	1.49	0.04
Unlevered Free Cash Flow Margin	-	-4.61	0.09	1.75	0.26
Asset Turnover
Asset Turnover	-	4.2	4	3.65	4.17
Fixed Assets Turnover	-	30.79	21.22	16.04	19.3
Receivables Turnover (Average Receivables)	-	9.79	9.2	9.54	13.5
Inventory Turnover (Average Inventory)	-	30.6	29.62	29.34	31.14
Short Term Liquidity
Current Ratio	1.34	1.75	1.72	1.64	1.53
Quick Ratio	1.13	1.37	1.43	1.34	1.2
Operating Cash Flow to Current Liabilities	0.3	-0.22	-0.05	-0.11	-0.02
Days Sales Outstanding (Average Receivables)	-	37.28	39.67	38.25	27.11
Days Outstanding Inventory (Average Inventory)	-	11.93	12.32	12.44	11.75
Average Days Payable Outstanding	-	33.92	34.54	35.7	32.99
Cash Conversion Cycle (Average Days)	-	15.28	17.45	14.99	5.88
Long Term Solvency
Total Debt/Equity	61.22	106.97	207.6	187.9	139.57
Total Debt / Total Capital	37.97	51.68	67.49	65.27	58.26
LT Debt/Equity	26.33	106.97	192.12	176.76	128.25
Long-Term Debt / Total Capital	16.33	51.68	62.46	61.4	53.53
Total Liabilities / Total Assets	70.31	76.02	80.99	81.12	77.04
EBIT / Interest Expense	13.65	0.64	1.63	-2.04	-2.28
EBITDA / Interest Expense	16.92	4.93	8.04	1.38	1.34
(EBITDA - Capex) / Interest Expense	5.97	-0.94	5.94	-0.54	-1.63
Total Debt / EBITDA	1.93	9.11	4.68	15.05	15.92
Net Debt / EBITDA	-0.34	5.2	3.35	7.81	8.25
Total Debt / (EBITDA - Capex)	5.48	-47.82	6.34	-38.46	-13.12
Net Debt / (EBITDA - Capex)	-0.95	-27.28	4.53	-19.96	-6.8
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	124.42	31.46	21.82	11.27	37.55
Gross Profit, 1 Yr. Growth %	131.18	31.55	22.2	-7.94	40.9
EBITDA, 1 Yr. Growth %	309.25	-62.99	75.75	-130	-41.12
EBITA, 1 Yr. Growth %	322.26	-94.02	510.98	-248.34	-10.2
EBIT, 1 Yr. Growth %	322.26	-94.02	510.98	-248.34	-10.2
Earnings From Cont. Operations, 1 Yr. Growth %	691.6	-100.48	-2.57K	-	-25.26
Net Income, 1 Yr. Growth %	691.6	-100.48	-2.57K	-	-28.31
Normalized Net Income, 1 Yr. Growth %	466.73	-97.52	629.3	277	-24.11
Diluted EPS Before Extra, 1 Yr. Growth %	-	-	-	-	-34.97
Accounts Receivable, 1 Yr. Growth %	-	38.3	22.36	-5.1	0.06
Inventory, 1 Yr. Growth %	-	56.54	5.64	22.19	36.22
Net Property, Plant and Equip., 1 Yr. Growth %	-	13.93	131.88	10.68	17.6
Total Assets, 1 Yr. Growth %	-	23.64	31.39	14.78	25.6
Tangible Book Value, 1 Yr. Growth %	-	-1.22	4.03	-368.08	-63.43
Common Equity, 1 Yr. Growth %	-	-0.14	4.15	-360.78	-71.42
Cash From Operations, 1 Yr. Growth %	-303.58	-170.72	-74.24	167.07	-72.72
Capital Expenditures, 1 Yr. Growth %	5.18	-31.9	-13.57	70.76	70.59
Levered Free Cash Flow, 1 Yr. Growth %	-	-	-98.94	1.11K	-95.41
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	-102.39	622.66	-76.51
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	71.76	25.95	16.42	23.71
Gross Profit, 2 Yr. CAGR %	-	74.39	15.96	6.07	10.82
EBITDA, 2 Yr. CAGR %	-	23.07	-30.9	-18.28	-40.15
EBITA, 2 Yr. CAGR %	-	-49.74	-49.78	279.47	34.89
EBIT, 2 Yr. CAGR %	-	-49.74	-49.78	279.47	34.89
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-80.54	-65.66	-	-
Net Income, 2 Yr. CAGR %	-	-80.54	-65.66	-	-
Normalized Net Income, 2 Yr. CAGR %	-	-62.53	-65.03	689.27	49.67
Accounts Receivable, 2 Yr. CAGR %	-	-	30.09	7.76	-2.55
Inventory, 2 Yr. CAGR %	-	-	28.6	13.61	29.01
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	62.54	60.2	14.08
Total Assets, 2 Yr. CAGR %	-	-	27.45	22.8	20.07
Tangible Book Value, 2 Yr. CAGR %	-	-	1.37	67	-0.99
Common Equity, 2 Yr. CAGR %	-	-	1.98	64.81	-13.67
Cash From Operations, 2 Yr. CAGR %	-	19.98	-57.32	-17.06	-14.64
Capital Expenditures, 2 Yr. CAGR %	-	-15.37	-23.28	21.49	70.68
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-	-34.15	-31.61
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-	-28.38	21.23
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	53.18	20.85	23.08
Gross Profit, 3 Yr. CAGR %	-	-	56.41	7.38	14.49
EBITDA, 3 Yr. CAGR %	-	-	38.59	-43.39	-7.26
EBITA, 3 Yr. CAGR %	-	-	15.56	-15.92	160.43
EBIT, 3 Yr. CAGR %	-	-	15.56	-15.92	160.43
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	-2.26	18	-
Net Income, 3 Yr. CAGR %	-	-	-2.26	-36.8	-
Normalized Net Income, 3 Yr. CAGR %	-	-	0.8	1.47	233.26
Accounts Receivable, 3 Yr. CAGR %	-	-	-	17.1	5.13
Inventory, 3 Yr. CAGR %	-	-	-	26.42	20.7
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	-	43	44.51
Total Assets, 3 Yr. CAGR %	-	-	-	23.08	23.73
Tangible Book Value, 3 Yr. CAGR %	-	-	-	40.18	0.66
Common Equity, 3 Yr. CAGR %	-	-	-	39.46	-8.1
Cash From Operations, 3 Yr. CAGR %	-	-	-28.16	-21.35	-42.75
Capital Expenditures, 3 Yr. CAGR %	-	-	-14.77	0.17	36.04
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	-74.4
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	-52.93
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	-	40.63
Gross Profit, 5 Yr. CAGR %	-	-	-	-	36.28
EBITDA, 5 Yr. CAGR %	-	-	-	-	3.85
EBITA, 5 Yr. CAGR %	-	-	-	-	34.86
EBIT, 5 Yr. CAGR %	-	-	-	-	34.86
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	-	57.6
Net Income, 5 Yr. CAGR %	-	-	-	-	7.46
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-	39.05
Cash From Operations, 5 Yr. CAGR %	-	-	-	-	-23.03
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-	12.52